Search Results - "Lamaj, E"

Alterations in homeostasis after open surgery. A prospective randomized study by Dedej, T, Lamaj, E, Marku, N, Ostreni, V, Bilali, S

“…Alterations in homeostasis, and a subsequent increased risk for postoperative thromboembolic complications, are observed as a result of open surgery…”
Get full text

Evaluating secondary acute myeloid leukemia (T-AML) post-breast cancer therapy: Case series from Albania by Çalliku, E., Barbullushi -Ruçaj, A., Dedej- Kurti, T., Lamaj, E., Semanaj, V., Perolla, A.

Get full text

PO-1514: Non-coplanar trajectory VMAT for treatment of spinal metastatic tumors by Van Timmeren, J., Lamaj, E., Ehrbar, S., Guckenberger, M., Tanadini-Lang, S.

Get full text

PO-1020 Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma by Vu, E., Lamaj, E., van Timmeren, J., Leonardi, C., Pytko, I., Marc, L., Guckenberger, M., Balermpas, P.

Get full text

Epidemiology of chronic lymphoid leukemia in Albania for the period 2013–2017 by Shani, M., Barbullushi, A., Dedej-Kurti, T., Lamaj, E., Daja, P., Lika, A., Ngjela, X., Semanaj, V., Pulluqi, P.

Get full text

PP32.08 QUALITY ASSURANCE FOR X-RAY PROTECTIVE APPAREL BEYOND TEARS AND HOLES by Waschkies, C.F., Saltybaeva, N., Samara, E.T., Ekeberg, J., Pires, F., Nella, F., Venancio, F. Branco, Iff, M., Lamaj, E., van Rossum, J., Day, M., Tanadini-Lang, S., Guckenberger, M., Stüssi, A.

Get full text

Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies by Fonsatti, E, Altomonte, M, Coral, S, De Nardo, C, Lamaj, E, Sigalotti, L, Natali, P G, Maio, M

“…Over the past two decades, complement (C)-activating monoclonal antibodies (mAb), directed to specific tumor-associated antigens (TAA), have been extensively…”
Get more information

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings by BELLI, Filiberto, TESTORI, Alessandro, CARRABBA, Matteo, SCITA, Giorgio, SANTANTONIO, Cristina, PILLA, Lorenzo, TRAGNI, Gabrina, LOMBARDO, Claudia, ARIENTI, Flavio, MARCHIANO, Alfonso, QUEIROLO, Paola, BERTOLINI, Francesco, RIVOLTINI, Licia, COVA, Agata, LAMAJ, Elda, ASCANI, Lucio, CAMERINI, Roberto, CORSI, Marco, CASCINELLI, Natale, LEWIS, Jonathan J, SRIVASTAVA, Pramod, PARMIANI, Giorgio, MAIO, Michele, ANDREOLA, Giovanna, SERTOLI, Mario Roberto, GALLINO, Gianfrancesco, PIRIS, Adriano, CATTELAN, Alessandro, LAZZARI, Ivano

“…To determine the immunogenicity and antitumor activity of a vaccine consisting of autologous, tumor-derived heat shock protein gp96-peptide complexes…”
Get full text

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients by PILLA, Lorenzo, PATUZZO, Roberto, TOSI, Diego, ARIENTI, Flavio, COVA, Agata, SOVENA, Gloria, PIRIS, Adriano, NONAKA, Daisuke, BERSANI, Ilaria, DI FLORIO, Annabella, LUIGI, Mariani, SRIVASTAVA, Pramod K, RIVOLTINI, Licia, HOOS, Axel, SANTINAMI, Mario, PARMIANI, Giorgio, MAIO, Michele, PENNACCHIOLI, Elisabetta, LAMAJ, Elda, MAURICHI, Andrea, MASSARUT, Samuele, MARCHIANO, Alfonso, SANTANTONIO, Cristina

“…The aim of this study was to determine the immunogenicity and antitumor activity of autologous, tumor-derived heat shock protein gp96-peptide complex vaccine…”
Get full text

Epigenetic Modulation of Solid Tumors as a Novel Approach for Cancer Immunotherapy by Sigalotti, Luca, Coral, Sandra, Fratta, Elisabetta, Lamaj, Elda, Danielli, Riccardo, Di Giacomo, Anna Maria, Altomonte, Maresa, Maio, Michele

“…Emerging evidence demonstrates that epigenetic events associated with tumor development and progression may impair immunogenicity and immune recognition of…”
Get full text

Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells by MAIO, Michele, FONSATTI, Ester, PARMIANI, Giorgio, LAMAJ, Elda, ALTOMONTE, Maresa, CATTAROSSI, Ilaria, SANTANTONIO, Cristina, MELANI, Cecilia, BELLI, Filiberto, ARIENTI, Flavio, COLOMBO, Mario P

“…The antibody (Ab) response to allogeneic Me14932 and autologous melanoma cells was analyzed in 13 Stage IV (AJCC) melanoma patients immunized with Me14932…”
Get full text

Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions by ALTOMONTE, M, FONSATTI, E, LAMAJ, E, CATTAROSSI, I, CATTELAN, A, MAIO, M

“…To date, no soluble markers can discriminate benign from malignant breast lesions; therefore, to assess the diagnostic potential of circulating intercellular…”
Get full text

Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review) by Maio, M, Brasoveanu, L I, Coral, S, Sigalotti, L, Lamaj, E, Gasparollo, A, Visintin, A, Altomonte, M, Fonsatti, E

“…Protectin (CD59) is a glycosyl-phosphatidylinositol-anchored cell membrane glycoprotein, ubiquitously expressed, though to a different extent, on benign and…”
Get more information

In vitro analysis of the melanoma/endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cells by FONSATTI, E, LAMAJ, E, CORAL, S, SIGALOTTI, L, NARDI, G, GASPAROLLO, A, COLOMBO, M. P, ALTOMONTE, M, MAIO, M

“…Melanoma cells constitutively release intercellular adhesion molecule 1 (ICAM-1) as soluble ICAM-1 (sICAM-1), and its levels are elevated in melanoma patients…”
Get full text